Therefore, disruption of the PPIs between AF9/ENL and AF4/AFF4 or DOT1L is a potentially useful therapy for MLL-r leukemia by suppressing SEC-mediated gene expression and DOT1L-caused H3K79 methylation [26]. This evidence concerns the gene DOT1L and leukemia.